Watchlist Price Alert

Insulet Corporation (PODD)

NASDAQ: PODD · Real-Time Price · USD

305.89

1.26 (0.41%)

At close: Jun 16, 2025, 3:59 PM

306.64

0.24%

After-hours: Jun 16, 2025, 06:40 PM EDT

0.41% (1D)

Bid	306.64
Market Cap	21.53B
Revenue (ttm)	2.03B
Net Income (ttm)	402.2M
EPS (ttm)	5.54
PE Ratio (ttm)	55.22
Forward PE	55.86
Analyst	Buy

Ask	311
Volume	622,761
Avg. Volume (20D)	862,723
Open	306.74
Previous Close	304.63
Day's Range	304.90 - 310.06
52-Week Range	173.00 - 329.33
Beta	1.38

About PODD

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol PODD

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for PODD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

1 month ago

+20.88%

Insulet shares are trading higher after the compan... Unlock content with Pro Subscription

1 month ago

-2.77%

Insulet shares are trading higher after the company reported better-than-expected Q1 financial results and raised its FY25 sales guidance above estimates. Also, the company issued Q2 sales guidance above estimates.

News

5 days ago · zacks.com

Here's Why You Should Retain PODD Stock in Your Portfolio Now

Insulet's Omnipod 5 gains traction with global expansion and rising Type 2 adoption despite economic and competitive hurdles.

6 days ago · businesswire.com

Insulet's Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod® 5 App for iPhone is now compatible wi...

1 week ago · marketbeat.com

3 Medical Technology Stocks Outperforming in 2025

As the broader market stages a sharp rebound from its April lows, several sectors, industries, and stocks have quietly emerged as leaders. Among them, the medical technology industry, known for its in...

1 week ago · zacks.com

Here's Why Insulet (PODD) is a Strong Growth Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

1 week ago · zacks.com

S&P 500 Wraps Up Best May Since 1990: 5 Top Stocks in the ETF

SPY jumped 6.3% in May, the most in decades, led by standout gains in NRG, STX, CEG, PODD and MCHP amid easing trade fears.

3 weeks ago · zacks.com

Insulet Gains 78.5% in a Year: What's Driving the Stock?

PODD's shares rise on the back of Omnipod 5's growth, global expansion, and strong Q1 2025 gains despite rising operating costs and macro headwinds.

3 weeks ago · businesswire.com

Insulet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025

ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced that management ...

3 weeks ago · zacks.com

4 Medical Product Stocks to Watch From a Challenging Industry

The U.S. government's tariff imposition, especially on China, is likely to keep supply chains under pressure for the Zacks Medical Products industry. PODD, MGNX, CLRB and ALUR reflect the favorable fu...